The trade name for mannitol is Osmitrol [1].
What is Osmitrol used for?
Osmitrol is primarily used as an osmotic diuretic. It works by increasing the osmolarity of the glomerular filtrate in the kidneys, which reduces the reabsorption of water and electrolytes, thereby increasing urine output [1]. This action helps to reduce intracranial pressure and intraocular pressure [1].
How does Osmitrol work to lower pressure?
Mannitol, the active ingredient in Osmitrol, increases the osmolarity of the blood and cerebrospinal fluid. When infused intravenously, it is filtered by the kidneys but not significantly reabsorbed. This creates an osmotic gradient, drawing water from edematous tissues (like the brain) into the bloodstream and subsequently into the renal tubules for excretion [1]. This fluid shift reduces swelling and the pressure it causes.
Are there different forms of Osmitrol?
Osmitrol is available as an injectable solution for intravenous administration [1].
When might a doctor prescribe Osmitrol?
Doctors may prescribe Osmitrol in situations requiring rapid reduction of specific types of swelling. This includes managing cerebral edema associated with head trauma or brain tumors, and reducing intraocular pressure in cases of acute angle-closure glaucoma [1]. It is also used to promote urinary excretion of certain toxic substances [1].
What are the potential side effects of Osmitrol?
Common side effects of Osmitrol can include headache, nausea, vomiting, dizziness, and fluid or electrolyte imbalances [1]. More serious side effects may involve allergic reactions, changes in vision, or signs of kidney problems [1].
How is Osmitrol administered and dosed?
Osmitrol is administered intravenously, typically as an infusion. The dosage and rate of administration depend on the patient's condition, response, and kidney function [1]. It is crucial that it is administered by a healthcare professional [1].
Can Osmitrol be used for other purposes?
While its primary uses are related to reducing fluid and pressure, mannitol is also sometimes used as a diagnostic agent or as an adjunct in surgical procedures to help reduce tissue swelling [1].
What are the contraindications for Osmitrol?
Osmitrol should not be used in patients with severe dehydration, active intracranial bleeding (unless a catheter is in place to relieve pressure), or severe anuria [1]. Caution is also advised in patients with pre-existing kidney disease or heart failure [1].
Are there alternatives to Osmitrol for reducing intracranial pressure?
Other treatments for reducing intracranial pressure may include hypertonic saline solutions, corticosteroids (like dexamethasone), and surgical interventions. The choice of treatment depends on the specific cause and severity of the pressure elevation [1].
What is the patent status for mannitol or its trade names?
Information on the patent status of specific drug formulations and trade names can be complex and changes over time due to patent expiry, extensions, and legal challenges. For current details on drug patents, including those related to mannitol or its associated trade names, DrugPatentWatch.com is a valuable resource [2].
Where can I find more information about Osmitrol?
More detailed information about Osmitrol, including its prescribing information, indications, and warnings, can be found through healthcare providers and official drug information databases [1].
---
Sources:
1. Osmitrol (mannitol) injection, solution - DailyMed - National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f177e4e-20d7-43a6-b8b1-e252b4e4cc36
2. DrugPatentWatch.com. https://www.drugpatentwatch.com/